Potential Treatment for Cystic Fibrosis Lung Infections Earns Orphan Drug Designation
According to a story from prnewswire.com, the biopharmaceutical company Aridis Pharmaceuticals, Inc. has recently announced that the US Food and Drug Administration (FDA) has awarded Orphan Drug designation to the…